Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis

Surgery

Volumn 131, Issue 1 SUPPL., 2002, Pages

  Emi, Yasunori ^a   Kitamura, Kaoru ^a   Shikada, Yasunori ^a   Kakeji, Yoshihiro ^a   Takahashi, Ikuo ^a   Tsutsui, Shinichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SCORING SYSTEM; SOFT TISSUE CANCER; SURVIVAL TIME; TUMOR GROWTH;

EID: 0036160735     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.119580     Document Type: Article

References (24)

1. Prognostic factors for breast cancer: Have they met their promise?
2. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer
3. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
4. Development and use of a natural history data base of breast cancer studies
5. Impact of axillary lymph node dissection no the therapy of breast cancer patients
6. Prognostic factors in metastatic breast cancer treated with combination chemotherapy
7. Survival from first recurrence: Relative importance of prognostic factors in 1,015 breast cancer patinets
8. Prognostic factors in recurrent breast cancer: Relationship to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading
9. Prognostic factors in metastatic breast cancer
10. The natural history of breast cancer patients with brain metastases
11. Clinical course of breast cancer patients with liver metastases
12. Survival after first recurrence in breast cancer
13. Specificity within the EGF family/erbB receptor family signalling network
14. Receptor protein-tyrosine kinases and their signal transduction pathways
15. Assessment of HER2 status in breast cancer: Why, when and how?
16. Studies of the HER2/neu protooncogene in human breast and ovarian cancer
17. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
18. The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy
19. Concordance in judgments among c-erB-2(HER2/neu) overexpression detected by two immunohistochemical tests and gene amplification detected by Southern blot hybridization in breast carcinoma
20. Steroid-hormone receptors and survival after first relapse in breast cancer
21. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast
22. Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer